Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model

Summary

Here we present a protocol for the induction of left ventricular cryoinjury followed by the implantation of a cardiac muscle patch, derived from human iPS-cell cardiomyocytes in a guinea pig model.

Abstract

Due to the limited regeneration capacity of the heart in adult mammals, myocardial infarction results in an irreversible loss of cardiomyocytes. This loss of relevant amounts of heart muscle mass can lead to the heart failure. Besides heart transplantation, there is no curative treatment option for the end-stage heart failure. In times of organ donor shortage, organ independent treatment modalities are needed. Left-ventricular assist devices are a promising therapy option, however, especially as destination therapy, limited by its side-effects like stroke, infections and bleedings. In recent years, several cardiac repair strategies including stem cell injection, cardiac progenitors or myocardial tissue engineering have been investigated. Recent improvements in cell biology allow for the differentiation of large amounts of cardiomyocytes derived from human induced pluripotent stem cells (iPSC). One of the cardiac repair strategies currently under evaluation is to transplant artificial heart tissue. Engineered heart tissue (EHT) is a three-dimensional in vitro created cardiomyocyte network, with functional properties of native heart tissue. We have created EHT-patches from hiPSC derived cardiomyocytes. Here we present a protocol for the induction of left ventricular myocardial cryoinjury in a guinea pig, followed by implantation of hiPSC derived EHT on the left ventricular wall.

Introduction

The number of patients with heart failure is increasing in our aging population. For end-stage heart failure, orthotopic heart transplantation is the only curative treatment option. However, especially in European countries, there is an increasing organ donor shortage. Therefore, alternative treatment options are necessary. Recent achievements in mechanical circulatory support are promising, but especially in the long-term run, limited by its side effects like bleeding, pump thrombosis and infectious complications¹.

The endogenous regeneration capacity of the adult human heart is extremely limited. Therefore, cardiac regeneration therapies might become an alternative treatment option for end-stage heart failure patients^2,3. Different techniques including stem cell-based cell injection or tissue engineering approaches have been described^3,4,5.

Human induced pluripotent stem cells (hiPSC), as well as human embryonic stem cells (hESC) can be effectively differentiated to spontaneously beating human cardiomyocytes⁶, which has been a major achievement in the field of cardiac regenerative therapies.

To replace myocardium after a myocardial infarction and to improve the function of a failing heart, survival of a suitable number of cardiomyocytes and their mechanical and electrical coupling with the native heart is essential. To investigate the potential of cardiac regenerative therapies with human iPS cell derived cardiomyocytes, a suitable research model is needed. The ideal model should be cost-effective and have a human-like physiology and electrophysiology. Large animal models like pigs would be ideal from that point of view, however, those experiments are very expensive and large amounts of cardiomyocytes would be necessary to replace a relevant number of cardiomyocytes in order to see effects on the left ventricular function in a pig infarction model.

To answer elementary biological questions towards human cell-based cardiac regeneration, e.g., cell survival, vascularization, and electrical coupling, small animal models are more suitable. From the available small animal models, the guinea pig is the most useful species, as compared to rats and mice, as their electrophysiology more closely resembles the situation in humans⁷. In this guinea pig model, we induced a transmural cryoinjury of the left ventricle. One week after induction of myocardial infarction implantation of a three-dimensional, spontaneously beating hiPS-cell derived cardiomyocyte patch was performed. Cardiomyocyte cell survival was evaluated 28 days after implantation by histological examination.

Protocol

Animals received humane care in compliance with the Guide for the Principles of Laboratory Animals, prepared by the Institute of Laboratory Animal Resources, and published by the National Institutes of Health. All animal protocols were approved by the responsible local authority (‘‘Amt für Gesundheit und Verbraucherschutz, Hansestadt Hamburg’’/ Animal protocol # 109/16).

1. Obtain Animals

1. Commercially obtain female Guinea pigs weighing 500–600 g.
2. House them under conventional conditions in animal cages. Feed standard rat chow and autoclaved water ad libidum.

2. Transthoracic Echocardiography

1. Place the guinea pig in an induction chamber and anesthetize the animal with isoflurane (2–3%). Check the depth of anesthesia by lack of response to the toe-pinch. 
2. Place the anesthetized Guinea pig on a warming platform (40–42 °C) in a supine position. Continue anesthesia via a nose cone (isoflurane 1.5-2%)
3. Shave and depilate the guinea pig´s thorax using an electric animal hair shaver.
4. Apply prewarmed (~25 °C) ultrasound transducer gel. Use an echocardiography system that is equipped with a transducer frequency higher than 15 MHz.
5. Acquire two-dimensional parasternal long axis views by placing the transducer on the guinea´s pig thorax facing from the right neck towards the left leg and record long axis B-mode images at the plane of the aortic valve with a concurrent visualization of the LV apex. Investigate the pre-operative left-ventricular function.
6. Turn the transducer by 90° degrees to obtain a short axis B-mode view at the mid-papillary level.
   NOTE: The animal is then immediately transferred to the OR table. The animal is continuously anesthetized with 3% isoflurane. 0.05 mg/kg atropine (i.m.) is injected to avoid increased bronchial secretion during mechanical ventilation.

3. Surgery

1. Induction of Myocardial infarction
   1. Inject 4–5 mg/kg carprofen and 0.05 mg/kg buprenorphine for analgesia subcutaneously with a 21 G needle and a 10 mL syringe. 0.5 mg/kg Atropine is injected subcutaneously with a 21 G needle and a 10 mL syringe.
   2. Place the guinea pig on its back and keep anesthesia with a facemask covering mouth and nose. Check the depth of anesthesia by pinching the hind feet (lack of pedal reflex).
   3. Spread the guinea pigs’ legs and fix the position using tape.
   4. Shave the chest and the tracheal region of the anesthetized animal with an electric shaver. Disinfect the area widely using iodine-based scrub, followed by 80% ethanol. Repeat this disinfection steps twice.
   5. Perform a 1.5 cm vertical incision in the tracheal area and bluntly dissect the muscles covering the trachea until you see the trachea. Puncture the trachea with 18 G i.v. cannula and insert the flexible part of the cannula as a tracheal tube.
   6. Connect the tracheal tube to an animal respirator to continuously ventilate the guinea pig during the procedure.
      NOTE: Now the anesthesia is maintained with isoflurane 3% via the tracheal tube (inspiration assisted ventilation with maximum inspiration pressure, respiration rate: 100–120/min, peak inspiration pressure: 18-22 cm Hg using PEEP-ventilation while the chest is open).
   7. Identify the 5^th intercostal space by counting the rib spaces beginning at the first intercostal space. Perform a 2 cm horizontal incision on the 5th intercostal space on the left side of the guinea pig using scissors and a tweezer. Insert a small animal retractor. Dissect the muscles with an electrocautery until the intercostal muscles are reached, which can be seen after removing the subcutaneous tissue, are reached.
   8. Gently dissect the intercostal muscles with tweezers until the pleural space is reached and one can see the left lung in front. Insert the retractor between the ribs and open it carefully until a good view of the heart is obtained.
   9. Open the pericardium approximately 1 cm in the region of the anterior left ventricular wall with scissors. Place a compress on the left lung to protect it from damage when inducing the cryoinjury of the left ventricle.
   10. Place the tip of an eroded metal stamp (aluminum) with a cross-sectional diameter of 0.5 cm into liquid nitrogen for 3 min.
   11. Press the nitrogen cooled probe onto the left anterior wall of the heart for 30 s. Then separate it from the heart using an electric soldering iron (250 °C) which is placed inside the stamp to warm it up. Repeat this procedure 3 times to obtain a transmural myocardial injury. Observe the blanching of the myocardium.
   12. Inflate the lungs with maximum pressure (by clamping the outflow tube of the ventilator for 2 s), to avoid atelectasis of the lung. Remove the retractor from the intercostal space.
   13. Close the ribs with two 3-0 sutures. Close the muscles over the ribs with a 4-0 running suture. For closure of the skin use 5-0 suture single stitches.
   14. Reduce the isoflurane to 1%. When the animal is breathing spontaneously, remove the tracheal tube, and continue anesthesia with a facemask (isoflurane 2–3%).
   15. Assure the absence of reflexes by pinching the hind limb to monitor sufficient depth of anesthesia. Then use a single 8-0 suture to close the puncture site at the trachea. Close the wound with three single stich 4-0 sutures.
   16. Use buprenorphine (0.05 mg/kg per 12 h) and carprofen (5 mg/kg per 24 h) for pain medication for the following 5 days.
2. Implantation of EHT (7 days after cryoinjury)
   1. Place the guinea pig in an induction chamber and anesthetize the animal with isoflurane Check the depth of anesthesia by the lack of response to the toe-pinch.
   2. Inject 4–5 mg/kg carprofen and 0.05 mg/kg buprenorphine subcutaneously with a 21 G needle and a 10 mL syringe after induction of anesthesia. Place the guinea pig on its back and keep anesthesia with a facemask covering mouth and nose.
      NOTE: Sufficiency of anesthesia should be checked by pinching the hind feet.
   3. Spread the guinea pig’s legs and fix the position using tape.
   4. Perform the pre-surgical preparations as described in step 3.1.4–3.1.6. Perform a 2 cm horizontal skin incision in the scar area of the left lateral side using scissors and tweezers.
   5. Gently dissect the extrapleural adhesions using an electrocautery. Carefully open the pleural space with scissors. Insert a rib spreader to expose the heart.
   6. Visually identify the region of the infarction by its pale color in comparison to the healthy surrounding myocardium. Place the engineered heart tissue patch over the infarction region.
   7. Secure it with two 8-0 sutures at both sides. Make sure to secure the patch in the non-infarcted area of the heart (Figure 1). Inflate the lungs with pressure, to avoid atelectasis of the lung. Remove the retractor from the intercostal space.
   8. Close the ribs with two 3-0 sutures. Close the muscles over the ribs with a 4-0 running suture. For closure of the skin use 5-0 suture single stitches.
   9. Reduce the isoflurane to 1%. When the animal is breathing spontaneously, remove the tracheal tube, and continue anesthesia with a facemask (isoflurane 2–3%).
   10. Assure the absence of reflexes by pinching the hind limb to monitor sufficient depth of anesthesia. Then use a single 8-0 suture to close the puncture site at the trachea. Close the wound with three single stitch 4-0 sutures.
   11. Use buprenorphine (0.05 mg/kg per 12 h) and carprofen (5 mg/kg per 24 h) for pain medication for the following 5 days.
   12. Four weeks after EHT implantation perform a transthoracic echocardiography (as described in step 2) to monitor LV function over time.
       NOTE: The LV function is monitored before EHT implantation and 4 weeks after implantation to monitor for improvement of cardiac function by EHT implantation
   13. Euthanize the animal which IACUC approved protocol and surgically explant the heart for further analysis.

Results

This guinea pig model is a suitable model to investigate cardiac regeneration after implantation of hiPSC derived EHT-patches. It reproducibly leads to large transmural myocardial injuries. Scar size is evaluated by histology four weeks after cryoinjury. Mason trichrome staining reveals large transmural scars (Figure 2). Scar size was similar over a large number of injured animals reflecting a high degree of reproducibility⁸. On average 25% of the left ventricular myo...

Discussion

A variety of small animal models are available to study the effect that cell transplantation exerts on injured hearts^9,10,11. We chose a guinea pig model because of all small animal models its (electro)physiology resembles most closely that of humans. The advantages of small animal models are simple housing, manageable costs, and few workforces. In comparison with mice and rats, guinea pigs´ cardiac (electro)physiology is m...

Materials

Name	Company	Catalog Number	Comments
Ventilator (VetFlo Dual Mode)	Kent Scientific
Forene	abbvie	1000009819
Carprofen	Zoetis	256692
Atropin	Braun	PZN 00648037
Buprenorphin	Sigma
Metal stamp
Electric soldering iron	Claytools
3-0 prolene suture	Ethicon
4-0 prolene suture	Ethicon	662SLH
5-0 prolene suture	Ethicon	8710H
8-0 prolene suture	Ethicon	8841H
Tungsten Carbide Scissor	FST	No. 14568-12
Stainless sterilization Container	FST	No. 20890-51
Graefe Forceps	FST	No.11652-10
Extra fine Graefe Forceps	FST	No.11150-10
Forceps	FST	No. 11022-15
Halsted- Mosquito	FST	No. 13009-12
Forceps	FST	No.13003-10
Baby Mixter	FST	No. 13013-14
Needle holder (Castroviejo with Tungsten Casbide Jaws)	FST	No. 12565-14
Needle Holder (Halsey)	FST	No. 12501-13
Alm Retractor with Blumt Teeth	FST	No. 17008-07
Spring Scissor	FST	No. 15000-00
Compress 5x5	Fink + Walter	PZN 08821417
Venflon Pro Safety	Becton Dickinson	PZN11123964
Cautery High Temp 2"	Bovie Medical Corporation	0100607151011055